Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cel-Sci Corporation Common Stock
(NY:
CVM
)
1.805
+0.065 (+3.74%)
Delayed Quote
Updated: 12:25 PM EDT, Oct 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cel-Sci Corporation Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Why Urban Outfitters Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
↗
May 22, 2025
Via
Benzinga
CEL-SCI Announces Pricing of Public Offering
May 21, 2025
From
CEL-SCI Corporation
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
May 21, 2025
Via
Benzinga
CEL-SCI Announces Proposed Public Offering
May 21, 2025
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI’s Multikine Investigational Cancer Medicine Potentially Available for Commercialization by Summer 2025 in Saudi Arabia
May 21, 2025
From
CEL-SCI Corporation
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
May 20, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 20, 2025
Via
Benzinga
These stocks are moving in today's session
↗
May 20, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
CEL-SCI Announces Combination of Common Stock
May 19, 2025
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Reports Fiscal Second Quarter 2025 Financial Results
May 15, 2025
From
CEL-SCI Corporation
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
May 02, 2025
Via
Benzinga
CEL-SCI to File for Regulatory Approval of Multikine in Saudi Arabia—Pursuing Local Partnerships for Commercialization and Manufacturing to Serve Middle East and North Africa Market
April 23, 2025
From
CEL-SCI Corporation
Via
Business Wire
Which stocks are moving on Monday?
↗
April 14, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
April 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
April 11, 2025
Via
Benzinga
New Study in the Scientific Journal “Cancer Cell” Supports CEL-SCI’s Strategy to Seek Early Approval for Multikine in Head and Neck Cancer Based on Pre-Surgical Tumor Responses
April 08, 2025
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Reports New Data: Treatment with Multikine Resulted in up to 95% Improvement in Quality of Life for Head and Neck Cancer Patients
March 24, 2025
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Announces Closing of $2.5 Million Offering
March 18, 2025
From
CEL-SCI Corporation
Via
Business Wire
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
↗
March 18, 2025
Via
Benzinga
CEL-SCI Announces Pricing of $2.5 Million Offering
March 17, 2025
From
CEL-SCI Corporation
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
March 17, 2025
Via
Benzinga
CEL-SCI’s Head and Neck Cancer Registration Study Protocol Clears FDA Review—in Talks with Potential Partners Interested in Commercialization of Multikine
March 17, 2025
From
CEL-SCI Corporation
Via
Business Wire
Journal of the American Medical Association (JAMA) Study Provides Further Evidence that CEL-SCI’s Multikine Can Treat Unmet Need in ~70% of Head and Neck Patients Based on PD-L1 Expression
March 14, 2025
From
CEL-SCI Corporation
Via
Business Wire
Stay updated with the stocks that are on the move in today's pre-market session.
↗
February 20, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial
February 20, 2025
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks
February 18, 2025
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck Cancer
January 14, 2025
From
CEL-SCI Corporation
Via
Business Wire
CEL-SCI Announces Closing of $5 Million Offering
December 31, 2024
From
CEL-SCI Corporation
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 30, 2024
Via
Benzinga
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
↗
December 30, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
